TOP STORIES

• COMMENTARY There’s Room for Growth in Biosimilar Space, but Who Will Grab It?
  August 3, 2018

• BUSINESS AstraZeneca’s AI Translation System Could Bring Huge Impact If Materialized: Japan R&D Chief
  August 2, 2018

• BUSINESS Daiichi Sankyo Offloading 41 Off-Patent Drugs to Alfresa as It Sharpens Focus on Oncology
  August 1, 2018

• BUSINESS AI in Pharma - 2: Daiichi Sankyo Looks to Set Competitors Apart with Efficient Call Center
  August 1, 2018

• REGULATORY Inappropriate Drug Promotion at Clinics Involves Encouragement of Off-Label Use in Most Cases: Study
  July 31, 2018

• BUSINESS AI in Pharma - 1: Companies Going Digital in Sales Support but Still Embrace Rep Experience
  July 30, 2018

• BUSINESS Chugai Sees Solid Uptake for Tecentriq, Hemlibra but CEO Frets Pricing Stability
  July 27, 2018

• BUSINESS (Update) Eisai/Biogen Alzheimer’s Drug BAN2401 Slows Cognitive Decline by 30%
  July 26, 2018

• REGULATORY AMED Launches Study on Evaluating the Quality and Safety of Nucleic Acid Medicines to Promote Their Development
  July 25, 2018

• ACADEMIA Debut of siRNA Therapeutic Looming on Horizon; Alnylam’s Patisiran Might Be Filed in Japan Too
  July 24, 2018

• BUSINESS Daiichi Sankyo’s Herceptin Biosimilar Might Hit Market as Early as November, Breast Cancer Use Also Eyed
  July 23, 2018

• BUSINESS Maruho to Increase Information Supply to Non-Dermatologists Using Digital Technology
  July 23, 2018

• BUSINESS Steep Hikes in Prices of Chinese-Made APIs Could Hit Generic Makers Hard
  July 20, 2018

• REGULATORY Lawmakers Question Rationale for PMD Law Amendment as LDP Launches Debate
  July 19, 2018

• ACADEMIA Japanese Society of Medical Oncology to Update I/O Guidelines in October
  July 18, 2018

• BUSINESS Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo
  July 17, 2018

• TRENDS As Biosimilars Show Mixed Performances, Lantus Follow-On Is on a Roll
  July 13, 2018

• BUSINESS Otsuka Ventures into Antibody Space with Visterra Buyout
  July 12, 2018

• REGULATORY MHLW Selects 9 Priority Prefectures for Generic Promotion Project, but Leaves Tokyo Out
  July 12, 2018

• REGULATORY MHLW Official Expounds on “Authorized Biosimilar” Pricing, 50% Generic Rule Applies for “Biosame” Products
  July 11, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• …
• Next ›
• 最終 »